Nevertheless, the TXL, Ato, and TXL–Ato groups had substantially reduced VCAM‐1 and ICAM‐1 mRNA levels compared to the COPD + AS group. This evidence concerns the gene VCAM1 and chronic obstructive pulmonary disease.